1. Home
  2. MAIA vs PHUN Comparison

MAIA vs PHUN Comparison

Compare MAIA & PHUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAIA
  • PHUN
  • Stock Information
  • Founded
  • MAIA 2018
  • PHUN 2009
  • Country
  • MAIA United States
  • PHUN United States
  • Employees
  • MAIA N/A
  • PHUN N/A
  • Industry
  • MAIA Biotechnology: Pharmaceutical Preparations
  • PHUN EDP Services
  • Sector
  • MAIA Health Care
  • PHUN Technology
  • Exchange
  • MAIA Nasdaq
  • PHUN Nasdaq
  • Market Cap
  • MAIA 56.3M
  • PHUN 53.3M
  • IPO Year
  • MAIA 2022
  • PHUN N/A
  • Fundamental
  • Price
  • MAIA $1.59
  • PHUN $2.53
  • Analyst Decision
  • MAIA
  • PHUN Buy
  • Analyst Count
  • MAIA 0
  • PHUN 2
  • Target Price
  • MAIA N/A
  • PHUN $7.75
  • AVG Volume (30 Days)
  • MAIA 375.5K
  • PHUN 244.3K
  • Earning Date
  • MAIA 08-11-2025
  • PHUN 11-06-2025
  • Dividend Yield
  • MAIA N/A
  • PHUN N/A
  • EPS Growth
  • MAIA N/A
  • PHUN N/A
  • EPS
  • MAIA N/A
  • PHUN N/A
  • Revenue
  • MAIA N/A
  • PHUN $2,400,000.00
  • Revenue This Year
  • MAIA N/A
  • PHUN N/A
  • Revenue Next Year
  • MAIA N/A
  • PHUN $53.29
  • P/E Ratio
  • MAIA N/A
  • PHUN N/A
  • Revenue Growth
  • MAIA N/A
  • PHUN N/A
  • 52 Week Low
  • MAIA $1.40
  • PHUN $2.22
  • 52 Week High
  • MAIA $3.74
  • PHUN $14.60
  • Technical
  • Relative Strength Index (RSI)
  • MAIA 50.99
  • PHUN 40.87
  • Support Level
  • MAIA $1.46
  • PHUN $2.42
  • Resistance Level
  • MAIA $1.65
  • PHUN $2.70
  • Average True Range (ATR)
  • MAIA 0.09
  • PHUN 0.10
  • MACD
  • MAIA 0.01
  • PHUN 0.00
  • Stochastic Oscillator
  • MAIA 43.10
  • PHUN 33.33

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.

About PHUN Phunware Inc.

Phunware Inc is a software company. It is a cloud platform for mobile that provides companies with the products, solutions, and data and services necessary to engage, manage and monetize its mobile application audiences. It derives maximum revenue from United States. The company has two reportable segments: Software subscriptions and services; and Advertising. It derives maximum revenue from Software subscriptions and services.

Share on Social Networks: